Merlin BioMed Group
Overview
Merlin BioMed Group is a venture capital firm specializing in investments within the biotechnology and medical device sectors. The firm is based in Geneva, Illinois, United States. Merlin BioMed Group focuses on providing capital to early-stage and growth-stage companies in the biotechnology and medical device industries. Their investment strategy includes funding across various stages, from seed funding to pre-IPO rounds, with a particular emphasis on companies developing innovative solutions in healthcare. The firm's portfolio includes a diverse range of companies operating in the biotechnology and medical device sectors, reflecting their commitment to advancing healthcare through strategic investments. Merlin BioMed Group's approach combines financial support with strategic guidance to foster the growth and success of its portfolio companies, aiming to bring transformative healthcare solutions to market. Their investments are characterized by a focus on innovation, scalability, and the potential to address significant medical needs, positioning them as a key player in the venture capital landscape for healthcare innovation.
Investment Focus
- Innovative healthcare solutions
- Scalable business models
- Experienced management teams
Portfolio Companies
Reach Merlin BioMed Group directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Merlin BioMed Group
What sectors does Merlin BioMed Group invest in?
Merlin BioMed Group invests in Medical Devices and Biotechnology, and is based in Illinois, United States. Merlin BioMed Group is listed as a venture capital in the ConnectSafely investor database.
What stage does Merlin BioMed Group invest at?
Merlin BioMed Group backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does Merlin BioMed Group invest in?
Merlin BioMed Group invests across United States.
What companies has Merlin BioMed Group invested in?
Merlin BioMed Group's portfolio includes Illumina, Thermo Fisher Scientific, Boston Scientific, Medtronic and Stryker Corporation.
Last updated · Source: ConnectSafely investor database
